The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 26, 2018

Filed:

Aug. 04, 2015
Applicant:

Zoneone Pharma, Inc., San Francisco, CA (US);

Inventors:

Mark E. Hayes, San Francisco, CA (US);

Charles O. Noble, San Francisco, CA (US);

Francis C. Szoka, Jr., San Francisco, CA (US);

Assignee:

ZONEONE PHARMA, INC., San Francisco, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2006.01); A61K 31/7048 (2006.01); A61K 9/19 (2006.01); A61K 38/07 (2006.01); A61K 31/496 (2006.01); A61K 31/4196 (2006.01); A61K 31/337 (2006.01); A61K 47/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7048 (2013.01); A61K 9/127 (2013.01); A61K 9/1277 (2013.01); A61K 9/19 (2013.01); A61K 31/337 (2013.01); A61K 31/4196 (2013.01); A61K 31/496 (2013.01); A61K 38/07 (2013.01); A61K 47/02 (2013.01);
Abstract

The present invention provides liposome compositions containing sparingly soluble drugs that are used to treat life-threatening diseases. A preferred method of encapsulating a drug inside a liposome is by remote or active loading. However, this process as described in the literature has been limited to drugs that are freely soluble in aqueous solution or solubilized as a water-soluble complex. This invention describes compositions and methods for remote loading drugs with low water solubility (<2 mg/mL). In the preferred embodiment the drug in the solubilizing agent is mixed with the liposomes in aqueous suspension so that the concentration of solubilizing agent is lowered to below its capacity to completely solubilize the drug. This results in the drug precipitating but remote loading is capability retained. The process is scalable and the resulting drug-loaded liposomes are characterized by a high drug-to-lipid ratios and predictable drug retention when the liposome encapsulated drug is administered in patients.


Find Patent Forward Citations

Loading…